Lakefront Biotherapeutics (LKFT) Debt Ratio (2019 - 2025)

Lakefront Biotherapeutics (LKFT) has reported Debt Ratio for 6 consecutive years, with 0.0 the latest figure, recorded in Q4 2025.

• Quarterly Debt Ratio rose 21.41% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (up 21.41% YoY) and the FY2025 annual result came in at 0.0, up 21.41% from the prior year.
• Debt Ratio climbed to 0.0 in Q4 2025 per LKFT's latest filing, from 0.0 in the prior quarter.
• Over the last five years, Debt Ratio for LKFT reached as high as 0.0 in Q1 2022 and fell as low as 0.0 in Q4 2024.
• A 4-year average of 0.0 and a median of 0.0 in 2021 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2021 — Debt Ratio sank 98.67% — and 2025, when it gained 21.41%.
• Year by year, Debt Ratio stood at 0.0 in 2021, then jumped by 94.16% to 0.0 in 2022, then slumped by 98.41% to 0.0 in 2024, then rose by 21.41% to 0.0 in 2025.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.0, and 0.0 for Q4 2025, Q4 2024, and Q1 2022 respectively.